Biotech & Pharma

Standardizing Cell Therapy Production with Technology Facelift

30 sec read2 views0 listens

The cell therapy industry is transitioning toward standardized production by implementing closed, automated, and modular platforms to overcome the inherent variability of disparate manufacturing processes. For developers and tech professionals, this shift necessitates the integration of process analytical technologies, electronic batch records, and AI-driven predictive controls to ensure reproducibility and optimize culture conditions in real time. These digital transformations will ultimately lower costs and reduce reliance on end-point testing through data-driven quality predictions.

Read the full article at Genetic Engineering News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

HELIX AI Model Accurately Predicts RNA Splicing, Unlocks Precision Medicine

The HELIX AI framework integrates genomic sequence data with tissue-specific protein expression to accurately predict RNA splicing and transcript isoform usage across thirty human tissues. For tech professionals, this scalable deep-learning architect...

Ali Nemati

Biotech & Pharma1 day ago31 sec read

Mutating Antibodies for Easier Drug-Conjugate Manufacturing

Johns Hopkins University researchers have engineered a general-purpose antibody by installing six specific mutations on the fragment crystallizable region to serve as standardized attachment sites for drug-carrying nanoparticles and diagnostic marker...

Ali Nemati

Biotech & Pharma1 day ago29 sec read

Biomanufacturing Could Reshape Organ Transplantation

Biomanufacturing and xenotransplantation technologies are transitioning from experimental stages to clinical reality to address the global solid-organ shortage. For tech professionals, this shift necessitates the development of reproducible, GMP-grad...

Ali Nemati

Biotech & Pharma1 day ago28 sec read

STAT+: Pharmalittle: We're reading about biotech investors' mood, a former FDA head's confidence, and more

Biotech investors are increasingly less concerned about political risks associated with the "Make America Healthy Again" movement, prioritizing factors like interest rates and clinical data instead. Former FDA commissioner David Kessler expresses con...

Ali Nemati

Cybersecurity1 day ago22 sec read

Using 3D Printers To Make Circuit Boards

The Raccoon Lab demonstrates a method to rapidly prototype printed circuit boards (PCBs) using 3D printers and copper tape, reducing production time significantly. This approach is particularly useful for hobbyists and developers needing quick iterat...

Ali Nemati

Standardizing Cell Therapy Production with Technology Facelift

Related Articles

HELIX AI Model Accurately Predicts RNA Splicing, Unlocks Precision Medicine

Mutating Antibodies for Easier Drug-Conjugate Manufacturing

Biomanufacturing Could Reshape Organ Transplantation

STAT+: Pharmalittle: We're reading about biotech investors' mood, a former FDA head's confidence, and more

Using 3D Printers To Make Circuit Boards